Bioequivalence of erythromycin enteric-coated capsules in healthy volunteers

孙培红,李荣,崔一民,赵东方,孙忠民
DOI: https://doi.org/10.3321/j.issn:1009-7708.2001.04.005
2001-01-01
Abstract:To study relative bioavailability of domestic and imported erythromycin enteric-coated capsules in healthy vol-unteers.A single oral administration of 500mg domestic and imported erythromycin enteric-coated capsules were given to 20healthy male volunteers in randomized crossover study. The washout peried is one week. Microbiological assay was used to determinethe concentrations of erythromycin in human serum. The data were analyzed by 3p97 program.The pharmacokinetic param-eters after a sing1e oral administration of 500 mg domestic and imported erythromycin enterc-coated capsu1es were as follows: cmax(2.14 ±0.75) and (2.11 ±0.77) mg/L; tmax(3.10 ±0.58) and (3.30 ±0.64)h;AUC0-l0h(6.63 ±2.08) and (6.64 ±2.18)mg.h/L;AUC0-∞(7.38 ±2.34) and (7.46 ±2.41 ) mg.h/L; F0-∞(100.59 ±19.47)% respectively. Variance analysis and twoone-sided test were performed to parameters: cmax , AUC0-l0h,AUC0-∞. There was no significant difference. The twopreparations of erythromycin are of bioequivalence.
What problem does this paper attempt to address?